Pediatric Rheumatology International Trials Organisation
- Address
- Largo Gerolamo Gaslini 5, 16147 Genoa, Italy
Pediatric Rheumatology International Trials Organisation
The Pediatric Rheumatology International Trials Organisation is a specialized research network dedicated to advancing the understanding and treatment of rheumatic diseases in children and adolescents. With a primary focus on juvenile idiopathic arthritis and related inflammatory conditions, the organization conducts pivotal clinical trials to optimize therapeutic interventions for pediatric patients aged 1-17 years.
- Systemic Juvenile Idiopathic Arthritis (sJIA) treatment optimization
- Pharmacokinetic studies of biologic therapies in pediatric populations
- Dose-finding and safety evaluations for novel therapeutic agents
The organization's research portfolio emphasizes pharmacokinetic profiling and dose-response studies to establish evidence-based treatment protocols specifically tailored for pediatric rheumatology patients. Through rigorous clinical investigation, they work to identify optimal dosing regimens that balance therapeutic efficacy with safety considerations unique to children and adolescents with chronic inflammatory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pediatric Rheumatology International Trials Organisation
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Dose-Finding Study of Sarilumab in Pediatric Patients with Systemic Juvenile Idiopathic Arthritis | Sanofi-Aventis Recherche & Developpement | Phase II | Recruiting | Aug 2018 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sarilumab | 1 | Unknown | 2018-08-29 | 2018-08-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.